Skip to content
Search

Latest Stories

Covid boosters to be offered to over 40s

Britain's booster programme for Covid-19 vaccinations is set to be expanded following advice from scientists.

The government's Joint Committee on Vaccination and Immunization (JCVI) said today (November 15) that all healthy adults aged 40-49 should be offered a booster, six months after their second dose.


Previously, the booster programme was limited to those aged 50 and over, and the clinically vulnerable.

So far, some 12.6 million people have had a booster dose.

The latest advice comes after the UK Health Security Agency released data from a real-world study which found the booster gave over 90 per cent protection against symptomatic Covid-19 for people aged 50 years and older.

The JCVI also said that 16 and 17 year olds, who were initially offered only a single dose, should now get a second.

Professor Wei Shen Lim, chair, Covid-19 immunisation, JCVI said: “Booster vaccine doses in more vulnerable adults, and second vaccine doses in 16 – 17 year olds are important ways to increase our protection against Covid-19 infection and severe disease. These vaccinations will also help extend our protection into 2022.”

Following JCVI advise the UK has been using either the Pfizer-BioNTech vaccine, or the Moderna vaccine in the booster rollout.

The Medicines and Healthcare products Regulatory Agency (MHRA) has maintained that booster doses are safe and side-effects, if any, are either a sore arm or flu-like symptoms.

MHRA chief executive Dr June Raine welcomed JCVI's announcement on the extension of the booster campaign to 40-49 year olds.

"This further strengthens our ability to ensure people are protected against Covid-19 and saves lives. Our proactive monitoring of the safety of booster doses does not raise any new concerns," she said.

More For You

Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less